You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • OP0116 Cost-effectiveness and cost-utility analysis of treat-to-target versus usual care in early rheumatoid arthritis: Results of the dream registry

Citation Tools

Article menu
Download PDFPDF
Scientific Abstracts
Oral Presentations
Abstract Session: Epidemiololgy and health services
OP0116 Cost-effectiveness and cost-utility analysis of treat-to-target versus usual care in early rheumatoid arthritis: Results of the dream registry

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Vermeer M, Kievit W, Kuper I, et al
OP0116 Cost-effectiveness and cost-utility analysis of treat-to-target versus usual care in early rheumatoid arthritis: Results of the dream registry
Annals of the Rheumatic Diseases 2013;71:92.